WallStreetZenWallStreetZen
Analyst Ranking
Bottom 9%
#3777 out of 4119 analysts
Average Return
-66.08%
Win Rate
0%0 out of 6
Risk vs Reward
Poor
Good

Matt Larew's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
No Ratings Available
Matt Larew doesn't have any winning ratings in our database

Matt Larew's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Signify Health IncSGFY
2HoldN/AN/ADowngrades
3 months ago
Ginkgo Bioworks Holdings IncDNA
1BuyN/AN/AInitiates Coverage On
a year ago
Innovage Holding CorpINNV
2HoldN/AN/ADowngrades
a year ago
Maxcyte IncMXCT
1BuyN/AN/AInitiates Coverage On
a year ago
Zymergen IncZY
2HoldN/AN/ADowngrades
a year ago
Twist Bioscience CorpTWST
1BuyN/AN/AInitiates Coverage On
a year ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.